September 15th 2025
Optain Health secures $26 million in Series A funding to enhance AI-driven retinal disease detection and expand its technology.
September 14th 2025
Study details early detection of vision loss in AMD
July 15th 2024Researchers from the UKB Eye Clinic, in cooperation with the University of Bonn and in close collaboration with basic and clinical scientists, have examined patients with early forms of AMD. The researchers focused on the so-called iRORA lesions, which are very early anatomical signs of retinal damage.
Study zeroes in on new target for treatment of one type of macular degeneration
July 10th 2024A team of researchers at the Ohio State University found that in mice an enzyme related to cell growth and division is a culprit in the blood vessel invasion in the back of the eye that causes blurred central vision in wet AMD.
Study: Low-dose aspirin doesn't affect the incidence or progression of AMD
May 28th 2024Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the Aspirin in Reducing Events in the Elderly–AMD (ASPREE-AMD) study.